Naples Money Management LLC Buys Shares of 112 Intuitive Surgical, Inc. (NASDAQ:ISRG)

Naples Money Management LLC acquired a new stake in Intuitive Surgical, Inc. (NASDAQ:ISRG) in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 112 shares of the medical equipment provider’s stock, valued at approximately $38,000.

Several other institutional investors have also modified their holdings of the company. Knights of Columbus Asset Advisors LLC lifted its holdings in shares of Intuitive Surgical by 0.9% in the fourth quarter. Knights of Columbus Asset Advisors LLC now owns 11,462 shares of the medical equipment provider’s stock valued at $3,867,000 after buying an additional 98 shares during the period. Andrew Hill Investment Advisors Inc. acquired a new stake in shares of Intuitive Surgical in the fourth quarter valued at $1,505,000. Fidelis Capital Partners LLC lifted its holdings in shares of Intuitive Surgical by 4.6% in the fourth quarter. Fidelis Capital Partners LLC now owns 1,824 shares of the medical equipment provider’s stock valued at $615,000 after buying an additional 80 shares during the period. Western Wealth Management LLC lifted its holdings in shares of Intuitive Surgical by 2.9% in the fourth quarter. Western Wealth Management LLC now owns 3,623 shares of the medical equipment provider’s stock valued at $1,222,000 after buying an additional 103 shares during the period. Finally, Calamos Advisors LLC lifted its holdings in shares of Intuitive Surgical by 34.0% during the fourth quarter. Calamos Advisors LLC now owns 123,108 shares of the medical equipment provider’s stock valued at $41,532,000 after purchasing an additional 31,249 shares during the last quarter. Institutional investors and hedge funds own 83.64% of the company’s stock.

Insider Activity

In other news, CEO Gary S. Guthart sold 24,325 shares of the stock in a transaction dated Monday, January 29th. The stock was sold at an average price of $376.06, for a total transaction of $9,147,659.50. Following the transaction, the chief executive officer now owns 9,425 shares of the company’s stock, valued at approximately $3,544,365.50. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. In other news, CEO Gary S. Guthart sold 24,325 shares of the stock in a transaction dated Monday, January 29th. The stock was sold at an average price of $376.06, for a total transaction of $9,147,659.50. Following the transaction, the chief executive officer now owns 9,425 shares of the company’s stock, valued at approximately $3,544,365.50. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, VP Fredrik Widman sold 5,041 shares of the stock in a transaction dated Friday, March 15th. The shares were sold at an average price of $397.07, for a total value of $2,001,629.87. Following the transaction, the vice president now directly owns 110 shares in the company, valued at approximately $43,677.70. The disclosure for this sale can be found here. In the last quarter, insiders have sold 248,418 shares of company stock valued at $95,927,097. Insiders own 0.90% of the company’s stock.

Wall Street Analyst Weigh In

Several equities research analysts have recently commented on the company. Piper Sandler upped their target price on Intuitive Surgical from $425.00 to $435.00 and gave the company an “overweight” rating in a report on Friday. StockNews.com downgraded Intuitive Surgical from a “buy” rating to a “hold” rating in a report on Thursday, February 29th. BTIG Research upped their target price on Intuitive Surgical from $412.00 to $421.00 and gave the company a “buy” rating in a report on Friday. Stifel Nicolaus upped their target price on Intuitive Surgical from $420.00 to $430.00 and gave the company a “buy” rating in a report on Monday, April 8th. Finally, Raymond James upped their target price on Intuitive Surgical from $372.00 to $435.00 and gave the company an “outperform” rating in a report on Thursday, January 25th. Five analysts have rated the stock with a hold rating and fourteen have given a buy rating to the company’s stock. According to data from MarketBeat.com, Intuitive Surgical presently has a consensus rating of “Moderate Buy” and an average price target of $396.17.

Intuitive Surgical Price Performance

Shares of ISRG stock opened at $366.34 on Friday. Intuitive Surgical, Inc. has a fifty-two week low of $254.85 and a fifty-two week high of $403.76. The stock’s 50-day moving average is $386.84 and its two-hundred day moving average is $343.10. The firm has a market cap of $129.85 billion, a P/E ratio of 66.13, a PEG ratio of 5.78 and a beta of 1.36.

Intuitive Surgical (NASDAQ:ISRG) last issued its earnings results on Thursday, April 18th. The medical equipment provider reported $1.50 earnings per share for the quarter, topping the consensus estimate of $1.40 by $0.10. Intuitive Surgical had a return on equity of 13.27% and a net margin of 27.16%. The company had revenue of $1.89 billion for the quarter, compared to analyst estimates of $1.87 billion. During the same period in the prior year, the firm posted $1.00 EPS. The business’s revenue was up 11.5% compared to the same quarter last year. As a group, research analysts expect that Intuitive Surgical, Inc. will post 4.93 EPS for the current year.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.